Can histoplasmosis cause monocytosis (an increase in monocytes)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, histoplasmosis can cause monocytosis, as the body's immune response to the infection involves the production and mobilization of monocytes to combat the fungus. Histoplasmosis is a fungal infection caused by Histoplasma capsulatum that primarily affects the lungs but can disseminate throughout the body. When the body is infected with this fungus, it mounts an immune response that includes increased production and mobilization of monocytes, leading to monocytosis (elevated monocyte count in the blood) 1. This occurs because monocytes are key cells in the innate immune system that differentiate into macrophages, which are essential for engulfing and destroying the Histoplasma organisms. The fungus actually has a complex relationship with macrophages, as it can survive and replicate within them, which further stimulates the immune system to produce more monocytes. Monocytosis is typically more prominent in the acute and disseminated forms of histoplasmosis rather than in localized pulmonary disease. Other laboratory findings that may accompany histoplasmosis include anemia, thrombocytopenia, elevated liver enzymes, and increased inflammatory markers. Diagnosis typically requires fungal cultures, antigen testing, or histopathological examination of affected tissues.

Some key points to consider in the management of histoplasmosis include:

  • The use of liposomal amphotericin B as initial treatment for severe or moderately severe disease, followed by oral itraconazole for at least 12 months 1
  • The importance of monitoring electrolyte levels, renal function, and blood cell count in patients receiving amphotericin B 1
  • The potential for immune reconstitution inflammatory syndrome in patients with HIV/AIDS who are started on antiretroviral therapy while being treated for histoplasmosis 1

In terms of the evidence, the most recent and highest quality study is from 2009, which provides guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents 1. However, the 2007 study by the Infectious Diseases Society of America provides more detailed information on the management of histoplasmosis, including the use of liposomal amphotericin B and itraconazole 1. Overall, the evidence suggests that histoplasmosis can cause monocytosis, and that prompt and effective treatment is essential to prevent morbidity and mortality.

From the Research

Histoplasmosis and Monocytosis

  • Histoplasmosis is a systemic fungal infection that can cause a range of clinical syndromes, including acute pulmonary histoplasmosis, disseminated disease, and chronic pulmonary disease 2, 3, 4.
  • The diagnosis and management of histoplasmosis depend on understanding the geographic distribution, common clinical presentations, and tests used for diagnosis 4.
  • Monocytes and their derivatives play a crucial role in the response to fungal pathogens, including Histoplasma capsulatum, and can trigger signaling pathways that mediate direct effects like phagocytosis and cytokine production 5.
  • While the provided studies do not directly address the question of whether histoplasmosis can cause monocytosis, they do suggest that monocytes are involved in the immune response to Histoplasma capsulatum 5.
  • However, there is no direct evidence in the provided studies to confirm that histoplasmosis can cause an increase in monocytes (monocytosis) 2, 3, 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of histoplasmosis.

Expert opinion on pharmacotherapy, 2002

Research

Histoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management.

Seminars in respiratory and critical care medicine, 2015

Research

Monocytes and the Host Response to Fungal Pathogens.

Frontiers in cellular and infection microbiology, 2020

Research

Posaconazole as rescue therapy in African histoplasmosis.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.